We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Bioinformatics Platform Designed to Manage Research Data

By LabMedica International staff writers
Posted on 28 Feb 2012
A bioinformatics suite has been developed to handle structure activity relationship (SAR) analysis, chemical informatics, data capture, compound sourcing, and biochemical data management. More...
The solution will be used to register, query, browse, analyze, and visualize information across multiple research programs and project teams.

Dotmatics (Bishops Stortford, UK), a provider of informatics tools and scientific data management solutions to the international pharmaceutical and biotechnology industries, reported that it has licensed its bioinformatics suite to IRBM Science Park (Rome, Italy).

Stephen Gallagher, chief executive officer of Dotmatics, said, “Having had a fruitful working relationship with IRBM prior to its spin-off from Merck Sharpe & Dohme, it’s a great pleasure to be able to continue to work with IRBM Science Park as they create an informatics platform optimized for the sites new business model.”

Alberto Bresciani, head of screening technologies at IRBM Science Park, said, “Our choice of the Dotmatics software suite was based on our need for a reliable but flexible chemoinformatics environment capable of addressing data management and data analysis across a set of highly diverse projects. We have found the flexibility and ease of use of the Dotmatics tools to be perfectly aligned with our project teams needs, providing us with a unified platform from which to efficiently manage scientific data. The suite’s tools for sharing information across the organization have been a huge success, and Dotmatics’ support in customizing the software to our needs has been first rate. We are excited to be going forward with Dotmatics during this period of rapid expansion of IRBM Science Park’s operations and information management needs.”

By enabling discovery organizations to share and use their research information more efficiently, Dotmatics’ goals are to facilitate the generation of strategic knowledge, making the right information available to the right person, at the right time and to boost customers’ productivity by maximizing their information and knowledge awareness across the spectrum of their discovery activities.

Product highlights include (1) Browser, a web-based tool for querying, browsing, and visualizing biologic databases such as IDBS’ activity base and any chemical database. (2) Vortex, a world-class visualization and analytics platform for scientific and nonscientific data. (3) Gateway, a securely enables research teams to share information internally and with external partners. (4) Pinpoint, a powerful Oracle (Redwood Shores, CA, USA) chemical cartridge for querying and integrating chemical databases. Pinpoint is an indexing and search tool at a cost-effective price (developed in collaboration with Astex Therapeutics [Cambridge, UK]). (5) Register, a flexible and scalable chemical registration system. (6) Nucleus, a map and import biologic and nonbiologic data files into an Oracle database. (7) Lastly, Studies, a screening data management tool.

Created in October 2009 as a spin-off from Merck Research Laboratories’ basic research site in Rome (Italy), IRBM Science Park provides a wide range research services for drug discovery, organic chemistry, and biomedical sciences. IRBM Science Park additionally collaborates with major international pharmaceutical companies and research organizations toward the discovery of new small molecule and peptide therapeutics and biologics.

Related Links:

Dotmatics
IRBM Science Park



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.